ACCESS Newswire

    / Micreos Pharmaceuticals AG (“Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation, has entered into a strategic partnership with Northway Biotech (“NBT”), a Contract Development and Manufacturing Organization (CDMO)

    / General Atomics Aeronautical Systems, Inc. (GA-ASI) welcomes the U.S. Air Force’s designation for its Collaborative Combat Aircraft: the new uncrewed jet fighter will be called the YFQ-42A. The announcement on Monday followed an earlier USAF decision in 2024 that

    / General Atomics (GA) today announced the strategic acquisition of North Point Defense, Inc. (NPD), a leading provider of Signals Intelligence (SIGINT) exploitation software and sensor integration, by General Atomics Integrated Intelligence, Inc. (GA-III), formerly known as General Atomics Commonwealth

    / General Atomics Aeronautical Systems, Inc. (GA-ASI) continues to expand the role of unmanned aerial systems, demonstrating the first-ever Anti-Submarine Warfare (ASW) capability on an MQ-9B SeaGuardian®. In a groundbreaking test from January 20-30, 2025, a company-operated MQ-9B SeaGuardian successfully